Fiche plateforme


Type d'activité

R&D

Domaine d'activité

Protein-drug conjugates preparation & analysis

Description

Syndivia is developing a family of antibody-drug conjugates (ADC) based on proprietary and classical payload platforms (conjugation on Cys and Lys). Our proprietary site-specific conjugation methodology and novel release triggers have been elaborated to increase circulation half-life, maintain antibodies' effector functions and target affinities. Targeted cancer therapies, Antibody-Drug Conjugates

Mots clés

Targeted cancer therapies, Antibody-Drug Conjugates

Secteur

Privé

Territoire

Alsace

Membres de la plateforme


Fiche détaillée à télécharger